[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 558794, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 218551, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 382464, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 558874, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 2, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 8, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.965, "open": 0.98, "dayLow": 0.94, "dayHigh": 0.9919, "regularMarketPreviousClose": 0.965, "regularMarketOpen": 0.98, "regularMarketDayLow": 0.94, "regularMarketDayHigh": 0.9919, "payoutRatio": 0.0, "beta": 0.839, "forwardPE": -3.1387095, "volume": 273828, "regularMarketVolume": 273828, "averageVolume": 695649, "averageVolume10days": 442840, "averageDailyVolume10Day": 442840, "bid": 0.94, "ask": 1.24, "bidSize": 5, "askSize": 2, "marketCap": 97297712, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 1.67, "allTimeHigh": 10.0, "allTimeLow": 0.45, "fiftyDayAverage": 1.07954, "twoHundredDayAverage": 1.163, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 73606208, "profitMargins": 0.0, "floatShares": 84421008, "sharesOutstanding": 99997648, "sharesShort": 1863417, "sharesShortPriorMonth": 2199265, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0196, "heldPercentInsiders": 0.03763, "heldPercentInstitutions": 0.11585, "shortRatio": 2.37, "shortPercentOfFloat": 0.0202, "impliedSharesOutstanding": 99997648, "bookValue": 0.109, "priceToBook": 8.926605, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -34784616, "trailingEps": -0.29, "forwardEps": -0.31, "enterpriseToEbitda": -2.022, "52WeekChange": -0.3733766, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 0.973, "targetHighPrice": 8.943337, "targetLowPrice": 5.8534856, "targetMeanPrice": 7.7967877, "targetMedianPrice": 8.195164, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 11622408, "totalCashPerShare": 0.133, "ebitda": -36409240, "totalDebt": 134199, "quickRatio": 3.593, "currentRatio": 3.893, "debtToEquity": 1.404, "returnOnAssets": -1.48826, "returnOnEquity": -3.4798098, "freeCashflow": -15344989, "operatingCashflow": -24222644, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763762533, "regularMarketTime": 1763758800, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Cardiol Therapeutics Inc.", "epsTrailingTwelveMonths": -0.29, "epsForward": -0.31, "epsCurrentYear": -0.44, "priceEpsCurrentYear": -2.2113636, "fiftyDayAverageChange": -0.106540024, "fiftyDayAverageChangePercent": -0.098690204, "twoHundredDayAverageChange": -0.19, "twoHundredDayAverageChangePercent": -0.1633706, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "shortName": "Cardiol Therapeutics Inc.", "regularMarketChangePercent": 0.829017, "regularMarketPrice": 0.973, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": -0.3083208, "postMarketPrice": 0.97, "postMarketChange": -0.0029999614, "regularMarketChange": 0.00800002, "regularMarketDayRange": "0.94 - 0.9919", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 695649, "fiftyTwoWeekLowChange": 0.20199996, "fiftyTwoWeekLowChangePercent": 0.26199734, "fiftyTwoWeekRange": "0.771 - 1.67", "fiftyTwoWeekHighChange": -0.69699997, "fiftyTwoWeekHighChangePercent": -0.41736525, "fiftyTwoWeekChangePercent": -37.33766, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": true, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]